# Indegene Ltd (INDGN) > Exchange: NSE | Sector: Healthcare | ISIN: ## Price Current Price: ₹516.6 Day Change: +1.58% 52W High: ₹632.9 52W Low: ₹414 Market Cap: ₹12,256 Cr ## Valuation P/E: 27.99 P/B: 4.27 EPS: ₹18.22 Book Value: ₹119.56 Dividend Yield: 0.44% ## Returns 1Y Return: -0.23% ## Profitability ROE: 13.94% ROCE: 18.34% Debt/Equity: 0.05 Revenue Growth: 32.8% Profit Growth: -32.3% EBITDA Margin: 17.64% Operating Margin: 12.14% ## About Indegene Ltd is a Health Information Services company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place. Sector: Healthcare Industry: Health Information Services Sub Industry: Unknown ## Business Model Overview: Indegene Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Health Information Services. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare. Source: Derived from stock data Revenue Streams: - Domestic formulations - Exports and regulated markets - Specialty or institutional sales Operating Model: - Develops, manufactures, distributes, or services healthcare products across regulated channels. - Approvals, product mix, compliance quality, and R&D productivity shape growth. Recent Context: - Concall Transcript: Announcement under Regulation 30 (LODR)-Earnings Call Transcript - Announcement: Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order - BSE Filing: Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order ## Access Current tier: anonymous More history: Register free to see 4 more years. ## Data Freshness Quote Updated: 2026-05-25T16:00:08.172Z Price History Updated: 2026-05-25T05:29:27.209Z Latest Price History Date: 2026-05-24 Technicals Updated: 2026-05-25T05:29:27.209Z Quant Updated: 2026-05-25T05:29:27.209Z Sentiment Updated: 2026-05-25T05:29:27.209Z Financials Status: current Financials Updated: 2026-05-18T10:31:09.799Z Financials Last Attempt: 2026-05-18T10:31:09.799Z Financials Provider Tried: yahoo Latest P&L Period: FY25 Latest Balance Sheet Period: FY25 Latest Cash Flow Period: FY25 ## P&L (Mar 2020) Revenue: ₹553 Cr Operating Profit: ₹42 Cr (OPM 8%) Net Profit: ₹14 Cr Tax: ₹26 Cr ## Annual P&L History Mar 2020: Rev ₹553Cr | PAT ₹14Cr | OPM 8% Mar 2021: Rev ₹643Cr | PAT ₹-12Cr | OPM 22% Mar 2022: Rev ₹966Cr | PAT ₹149Cr | OPM 24% ## Balance Sheet (Mar 2020) Total Assets: ₹329 Cr Total Liabilities: ₹329 Cr Borrowings: ₹147 Cr Cash: ₹undefined Cr ## Shareholding undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% ## Board - Manish Gupta, Executive Chairman & CEO - Sanjay Suresh Parikh Ph.D., Executive Director & Executive VP - Suhas Prabhu ACA, BCom, Chief Financial Officer - Anand Kiran Prafula Chandra Nijegal, Executive Vice President of Global Operations - Tarun Mathur, Chief Technology Officer --- Source: rupiya.io/stocks/indgn Disclaimer: For research and education only. Not investment advice.